KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Short-Term Debt issuances (2017 - 2023)

Medpace Holdings (MEDP) has disclosed Short-Term Debt issuances for 3 consecutive years, with $15.0 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Short-Term Debt issuances fell 93.99% year-over-year to $15.0 million, compared with a TTM value of $15.0 million through Mar 2024, down 95.89%, and an annual FY2023 reading of $105.0 million, down 67.61% over the prior year.
  • Short-Term Debt issuances was $15.0 million for Q2 2023 at Medpace Holdings, down from $90.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $249.7 million in Q2 2022 and bottomed at $15.0 million in Q2 2023.